Marshall Wace North America’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.25M Buy
+14,051
New +$1.24M 0.01% 851
2020
Q3
Sell
-222,128
Closed -$18.4M 1332
2020
Q2
$18.4M Sell
222,128
-134,860
-38% -$11M 0.12% 191
2020
Q1
$27M Buy
356,988
+142,136
+66% +$12.2M 0.2% 133
2019
Q4
$20M Buy
214,852
+214,285
+37,793% +$18M 0.1% 199
2019
Q3
$47K Sell
567
-1,915
-77% -$152K ﹤0.01% 1165
2019
Q2
$205K Buy
+2,482
New +$213K ﹤0.01% 1038
2019
Q1
Sell
-22,312
Closed -$2.04M 1716
2018
Q4
$2.04M Buy
+22,312
New +$2.23M 0.02% 424
2018
Q2
Sell
-15,319
Closed -$1.98M 1526
2018
Q1
$1.98M Buy
+15,319
New +$2.05M 0.01% 811
2017
Q4
Sell
-20,733
Closed -$2.51M 1473
2017
Q3
$2.51M Buy
+20,733
New +$2.53M 0.02% 738
2017
Q2
Sell
-39,913
Closed -$4.79M 1366
2017
Q1
$4.79M Buy
+39,913
New +$4.88M 0.04% 403

Other funds holding INGR

Marshall Wace North America's INGR Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Ingredion (INGR) in Q3 2021: 14,051 shares worth $1.25M. The stake represents 0.01% of the portfolio and ranks #851 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in INGR as recently as Q2 2020.

Marshall Wace North America first reported a position in INGR in Q1 2017 and has held it in 10 quarters since. The position peaked at $27M in Q1 2020. 444 funds tracked by Wall St. Rank hold INGR as of Q3 2021.

  • Marshall Wace North America held 14,051 shares of Ingredion worth $1.25M as of Q3 2021.
  • Ingredion was a new Marshall Wace North America position in Q3 2021.
  • Ingredion made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #851 holding.
  • Marshall Wace North America first reported a position in Ingredion in Q1 2017 and has held it in 10 quarters since.
  • Marshall Wace North America's Ingredion position peaked at $27M in Q1 2020.
  • 444 funds tracked by Wall St. Rank held Ingredion as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.